CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 44 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $56,409 | -32.0% | 130,774 | +4.0% | 0.00% | – |
| Q4 2022 | $82,924 | -26.6% | 125,752 | -4.2% | 0.00% | – |
| Q3 2022 | $113,000 | +52.7% | 131,301 | -2.3% | 0.00% | – |
| Q2 2022 | $74,000 | -34.5% | 134,456 | +32.0% | 0.00% | – |
| Q1 2022 | $113,000 | -74.2% | 101,832 | -60.1% | 0.00% | – |
| Q4 2021 | $438,000 | -20.1% | 255,020 | +43.0% | 0.00% | – |
| Q3 2021 | $548,000 | -23.0% | 178,329 | -2.2% | 0.00% | – |
| Q2 2021 | $712,000 | +314.0% | 182,377 | +194.9% | 0.00% | – |
| Q1 2021 | $172,000 | -20.4% | 61,846 | -12.9% | 0.00% | – |
| Q4 2020 | $216,000 | +227.3% | 71,026 | +558.6% | 0.00% | – |
| Q3 2020 | $66,000 | +32.0% | 10,784 | -40.8% | 0.00% | – |
| Q4 2019 | $50,000 | -60.9% | 18,230 | +73.1% | 0.00% | – |
| Q3 2019 | $128,000 | -52.6% | 10,529 | -55.4% | 0.00% | – |
| Q2 2019 | $270,000 | – | 23,612 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 552 | $2 | 0.00% |